{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:07:24Z","timestamp":1791176844364,"version":"4.1.0"},"reference-count":0,"publisher":"BMJ","issue":"jul20 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[2010,7,20]]},"DOI":"10.1136\/bmj.c3493","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T19:33:11Z","timestamp":1279654391000},"page":"c3493-c3493","source":"Crossref","is-referenced-by-count":267,"title":["Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial"],"prefix":"10.1136","volume":"341","author":[{"name":"The FUTURE I\/II Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2010,7,20]]},"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.c3493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:06:47Z","timestamp":1601053607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.c3493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,20]]},"references-count":0,"journal-issue":{"issue":"jul20 1","published-online":{"date-parts":[[2010,7,20]]},"published-print":{"date-parts":[[2010,7,20]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.c3493","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,20]]}}}